{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T02:30:35Z","timestamp":1789353035565,"version":"build-2803163510"},"reference-count":72,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T00:00:00Z","timestamp":1748217600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023554","name":"Canary Foundation Canary Islands Health Research Institute","doi-asserted-by":"publisher","award":["PIFIISC20_05"],"award-info":[{"award-number":["PIFIISC20_05"]}],"id":[{"id":"10.13039\/501100023554","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.jad.2025.119443","type":"journal-article","created":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T11:39:25Z","timestamp":1747654765000},"page":"119443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Analysis of therapeutic adherence to antidepressants and associated factors in patients with depressive disorder: A population-based cohort study"],"prefix":"10.1016","volume":"385","author":[{"given":"Diego","family":"Infante-Ventura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjam\u00edn","family":"Rodr\u00edguez-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel \u00c1ngel","family":"Garc\u00eda Bello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Valc\u00e1rcel-Nazco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Estupi\u00f1\u00e1n-Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Javier","family":"Acosta Artiles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Gonz\u00e1lez de Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Hurtado-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasmania","family":"del Pino-Sede\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2025.119443_bb0005","series-title":"Utilizaci\u00f3n de medicamentos ansiol\u00edticos e hipn\u00f3ticos en Espa\u00f1a","author":"Agencia Espa\u00f1ola de Medicamentos y Productos Sanitarios","year":"2024"},{"key":"10.1016\/j.jad.2025.119443_bb0010","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1097\/01.mlr.0000254574.23418.f6","article-title":"Adherence to antidepressant treatment among privately insured patients diagnosed with depression","volume":"45","author":"Akincigil","year":"2007","journal-title":"Med. Care"},{"key":"10.1016\/j.jad.2025.119443_bb0015","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.3390\/ijerph20031994","article-title":"The role of lifestyle on adherence to treatment in a sample of patients with unipolar and bipolar depression","volume":"20","author":"Benatti","year":"2023","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.jad.2025.119443_bb0020","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00127-009-0041-5","article-title":"Non-adherence with psychotropic medications in the general population","volume":"45","author":"Bulloch","year":"2010","journal-title":"Soc. Psychiatry Psychiatr. Epidemiol."},{"key":"10.1016\/j.jad.2025.119443_bb0025","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1001\/archinte.158.16.1789","article-title":"The AUDIT alcohol consumption questions (AUDIT-C)an effective brief screening test for problem drinking","volume":"158","author":"Bush","year":"1998","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jad.2025.119443_bb0030","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1001\/jamapsychiatry.2017.1273","article-title":"Simultaneous antidepressant and benzodiazepine new use and subsequent long-term benzodiazepine use in adults with depression, United States, 2001-2014","volume":"74","author":"Bushnell","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2025.119443_bb0035","doi-asserted-by":"crossref","first-page":"9232","DOI":"10.3390\/ijerph17249232","article-title":"Diagnosis and treatment of depression in Spain: are there gender inequalities?","volume":"17","author":"Cabezas-Rodr\u00edguez","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.jad.2025.119443_bb0040","series-title":"Z. Bol. Can. Uso Racion. Medicam. SCS","first-page":"1","article-title":"Desprescripci\u00f3n de benzodiazepinas e hipn\u00f3ticos","volume":"9","author":"Castellano Cabrera","year":"2017"},{"key":"10.1016\/j.jad.2025.119443_bb0045","article-title":"Prevalence, progress, and subgroup disparities in pharmacological antidepressant treatment of those who screen positive for depressive symptoms: a repetitive cross-sectional study in 19 European countries","volume":"17","author":"Chen","year":"2022","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.jad.2025.119443_bb0050","doi-asserted-by":"crossref","first-page":"807","DOI":"10.46747\/cfp.6811807","article-title":"Individualized antidepressant therapy in patients with major depressive disorder: novel evidence-informed decision support tool","volume":"68","author":"Chin","year":"2022","journal-title":"Can. Fam. Physician"},{"key":"10.1016\/j.jad.2025.119443_bb0055","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2025.119443_bb0060","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3111\/13696998.2011.632043","article-title":"Early discontinuation and suboptimal dosing of duloxetine treatment in patients with major depressive disorder: analysis from a US third-party payer perspective","volume":"15","author":"Cui","year":"2012","journal-title":"J. Med. Econ."},{"key":"10.1016\/j.jad.2025.119443_bb0065","doi-asserted-by":"crossref","first-page":"e609","DOI":"10.3399\/bjgp17X691865","article-title":"Long-term benzodiazepine and Z-drugs use in England: a survey of general practice","volume":"67","author":"Davies","year":"2017","journal-title":"Br. J. Gen. Pract."},{"key":"10.1016\/j.jad.2025.119443_bb0070","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00228-013-1582-9","article-title":"Risk factors for non-adherence to antidepressant treatment in patients with mood disorders","volume":"70","author":"de las Cuevas","year":"2014","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jad.2025.119443_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1327155","article-title":"Sociodemographic and clinical predictors of adherence to antidepressants in depressive disorders: a systematic review with a meta-analysis","volume":"15","author":"del Pino-Sede\u00f1o","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jad.2025.119443_bb0080","doi-asserted-by":"crossref","first-page":"275","DOI":"10.2147\/PPA.S41609","article-title":"Systematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophrenia","volume":"7","author":"Dilla","year":"2013","journal-title":"Patient Prefer. Adherence"},{"key":"10.1016\/j.jad.2025.119443_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.rcsop.2023.100392","article-title":"US Medicaid program: an analysis of the spending and utilization patterns for antidepressants from 2017 to 2021","volume":"13","author":"Elmarasi","year":"2024","journal-title":"Exploratory Research in Clinical and Social Pharmacy"},{"key":"10.1016\/j.jad.2025.119443_bb0090","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"Ferrari","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.jad.2025.119443_bb0095","series-title":"Framework for FDA\u2019s Real-World Evidence Program","author":"Food and Drug Administration","year":"2018"},{"key":"10.1016\/j.jad.2025.119443_bb0100","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.jad.2013.07.004","article-title":"Treatment adherence towards prescribed medications in bipolar-II acute depressed patients: relationship with cyclothymic temperament and \u201ctherapeutic sensation seeking\u201d in response towards subjective intolerance to pain","volume":"151","author":"Fornaro","year":"2013","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.119443_bb0105","doi-asserted-by":"crossref","first-page":"827","DOI":"10.4088\/JCP.09m05528blu","article-title":"Reasons for antidepressant nonadherence among veterans treated in primary care clinics","volume":"72","author":"Fortney","year":"2011","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2025.119443_bb0110","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1524-4733.2007.00186.x","article-title":"Using real-world data for coverage and payment decisions: the ISPOR real-world data task force report","volume":"10","author":"Garrison","year":"2007","journal-title":"Value Health"},{"key":"10.1016\/j.jad.2025.119443_bb0115","series-title":"Global Burden of Disease Study 2021 (GBD 2021)","year":"2024"},{"key":"10.1016\/j.jad.2025.119443_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph192416788","article-title":"Barriers and facilitating factors of adherence to antidepressant treatments: an exploratory qualitative study with patients and psychiatrists","volume":"19","author":"Gonz\u00e1lez de Le\u00f3n","year":"2022","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.jad.2025.119443_bb0125","doi-asserted-by":"crossref","first-page":"899","DOI":"10.15288\/jsad.2012.73.899","article-title":"Systematic review: effect of alcohol intake on adherence to outpatient medication regimens for chronic diseases","volume":"73","author":"Grodensky","year":"2012","journal-title":"J. Stud. Alcohol Drugs"},{"key":"10.1016\/j.jad.2025.119443_bb0130","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1111\/j.1360-0443.1991.tb01879.x","article-title":"The Fagerstr\u00f6m test for nicotine dependence: a revision of the Fagerstrom tolerance questionnaire","volume":"86","author":"Heatherton","year":"1991","journal-title":"Br. J. Addict."},{"key":"10.1016\/j.jad.2025.119443_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jad.2015.12.029","article-title":"Clinical and economic impact of non-adherence to antidepressants in major depressive disorder: a systematic review","volume":"193","author":"Ho","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.119443_bb0140","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/fampra\/cmy106","article-title":"Non-adherence to antidepressants among older patients with depression: a longitudinal cohort study in primary care","volume":"36","author":"Holvast","year":"2019","journal-title":"Fam. Pract."},{"key":"10.1016\/j.jad.2025.119443_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/08870449908407311","article-title":"The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication","volume":"14","author":"Horne","year":"1999","journal-title":"Psychol. Health"},{"key":"10.1016\/j.jad.2025.119443_bb0150","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s40263-017-0417-0","article-title":"Adherence and persistence across antidepressant therapeutic classes: a retrospective claims analysis among insured US patients with major depressive disorder (MDD)","volume":"31","author":"Keyloun","year":"2017","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jad.2025.119443_bb0155","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1001\/jama.2017.5706","article-title":"Management of depression in older adults: a review","volume":"317","author":"Kok","year":"2017","journal-title":"JAMA-Journal of the American Medical Association"},{"key":"10.1016\/j.jad.2025.119443_bb0160","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.jad.2025.119443_bb0165","article-title":"Prescribing behavior of antidepressants for depressive disorders: a systematic review","volume":"13","author":"Lam","year":"2022","journal-title":"Front. Psych."},{"key":"10.1016\/j.jad.2025.119443_bb0170","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1176\/appi.ps.201400568","article-title":"Predictors of pharmacy-based measurement and self-report of antidepressant adherence: are individuals overestimating adherence?","volume":"67","author":"Leggett","year":"2016","journal-title":"PS"},{"key":"10.1016\/j.jad.2025.119443_bb0175","first-page":"63","article-title":"Adherence and persistence with branded antidepressants and generic SSRIs among managed care patients with major depressive disorder","volume":"3","author":"Liu","year":"2011","journal-title":"Clinicoecon Outcomes Res"},{"key":"10.1016\/j.jad.2025.119443_bb0180","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph181910213","article-title":"Interventions to improve medication adherence in patients with schizophrenia or bipolar disorders: a systematic review and meta-analysis","volume":"18","author":"Loots","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"10.1016\/j.jad.2025.119443_bb0185","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00228-011-1087-3","article-title":"New users of antidepressant medications: first episode duration and predictors of discontinuation","volume":"68","author":"Lu","year":"2012","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jad.2025.119443_bb0190","article-title":"National prescription patterns of antidepressants in the treatment of adults with major depression in the US between 1996 and 2015: a population representative survey based analysis","volume":"11","author":"Luo","year":"2020","journal-title":"Front. Psych."},{"key":"10.1016\/j.jad.2025.119443_bb0195","series-title":"Subdirecci\u00f3n General de Informaci\u00f3n Sanitaria. Salud mental en datos: prevalencia de los problemas de salud y consumo de psicof\u00e1rmacos y f\u00e1rmacos relacionados a partir de registros cl\u00ednicos de atenci\u00f3n primaria. BDCAP Series 2","author":"Ministerio de Sanidad","year":"2020"},{"key":"10.1016\/j.jad.2025.119443_bb0200","series-title":"Estrategia Nacional sobre Adicciones","author":"Ministerio de Sanidad, Servicio Sociales e Igualdad","year":"2017"},{"key":"10.1016\/j.jad.2025.119443_bb0205","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1097\/00005650-198601000-00007","article-title":"Concurrent and predictive validity of a self-reported measure of medication adherence","volume":"24","author":"Morisky","year":"1986","journal-title":"Med. Care"},{"key":"10.1016\/j.jad.2025.119443_bb0210","article-title":"Factors associated with non-adherence to anti-depressant medication in adults: a systematic review and meta-analysis","volume":"15","author":"Muhammad","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.jad.2025.119443_bb0215","series-title":"NICE Guideline [CG90], National Institute for Health and Care Excellence: Guidelines","article-title":"Depression in adults: recognition and management","author":"NICE","year":"2009"},{"key":"10.1016\/j.jad.2025.119443_bb0220","series-title":"NICE Guideline [NG222]., National Institute for Health and Care Excellence: Guidelines","article-title":"Depression in adults: treatment and management","author":"NICE","year":"2022"},{"key":"10.1016\/j.jad.2025.119443_bb0225","series-title":"Poblaci\u00f3n de 16 y m\u00e1s a\u00f1os seg\u00fan problemas de salud diagnosticados por un\/a m\u00e9dico\/a, sexos y grupos de edad. Diabetes","author":"Observatorio Canario de la Salud","year":"2021"},{"key":"10.1016\/j.jad.2025.119443_bb0230","series-title":"Poblaci\u00f3n de 16 y m\u00e1s a\u00f1os seg\u00fan problemas de salud diagnosticados por un\/a m\u00e9dico\/a, sexos y grupos de edad por a\u00f1os. Hipertensi\u00f3n","author":"Observatorio Canario de la Salud","year":"2021"},{"key":"10.1016\/j.jad.2025.119443_bb0235","series-title":"Prevalencia de sedentarismo","author":"Observatorio Canario de la Salud","year":"2021"},{"key":"10.1016\/j.jad.2025.119443_bb0240","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.aprim.2013.11.003","article-title":"Adherence to patients antidepressant treatment and the factors associated of non-compiance","volume":"46","author":"P\u00e1rraga Mart\u00ednez","year":"2014","journal-title":"Aten. Primaria"},{"key":"10.1016\/j.jad.2025.119443_bb0245","doi-asserted-by":"crossref","first-page":"2696","DOI":"10.3390\/pharmaceutics14122696","article-title":"Non-adherence to antidepressant treatment and related factors in a region of Spain: a population-based registry study","volume":"14","author":"Pedrosa-Naud\u00edn","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jad.2025.119443_bb0250","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1007\/s00228-013-1567-8","article-title":"Trend in SSRI-SNRI antidepressants prescription over a 6-year period and predictors of poor adherence","volume":"69","author":"Poluzzi","year":"2013","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.jad.2025.119443_bb0255","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jad.2019.04.018","article-title":"Psychotropic polypharmacy reconsidered: between-class polypharmacy in the context of multimorbidity in the treatment of depressive disorders","volume":"252","author":"Rhee","year":"2019","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2025.119443_bb0260","first-page":"151","article-title":"Sociodemographic and clinical predictors of compliance with antidepressants for depressive disorders: systematic review of observational studies","volume":"7","author":"Rivero-Santana","year":"2013","journal-title":"Patient Prefer. Adherence"},{"issue":"6","key":"10.1016\/j.jad.2025.119443_bb0265","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1001\/archinte.1979.03630430009004","article-title":"In search of the gold standard for compliance measurement","volume":"139","author":"Rudd","year":"1979","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jad.2025.119443_bb0270","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1176\/appi.ajp.2011.10111645","article-title":"Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study","volume":"168","author":"Rush","year":"2011","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2025.119443_bb0275","first-page":"41","article-title":"Antidepressant adherence: are patients taking their medications?","volume":"9","author":"Sansone","year":"2012","journal-title":"Innov. Clin. Neurosci."},{"key":"10.1016\/j.jad.2025.119443_bb0280","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jclinepi.2004.10.012","article-title":"A review of uses of health care utilization databases for epidemiologic research on therapeutics","volume":"58","author":"Schneeweiss","year":"2005","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jad.2025.119443_bb0285","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13643-020-1274-3","article-title":"Psychotropic medication non-adherence and its associated factors among patients with major psychiatric disorders: a systematic review and meta-analysis","volume":"9","author":"Semahegn","year":"2020","journal-title":"Syst. Rev."},{"key":"10.1016\/j.jad.2025.119443_bb0290","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1590\/1516-4446-2020-0935","article-title":"How can we improve antidepressant adherence in the management of depression? A targeted review and 10 clinical recommendations","volume":"43","author":"Solmi","year":"2021","journal-title":"Braz J Psychiatry"},{"key":"10.1016\/j.jad.2025.119443_bb0295","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0895-4356(96)00268-5","article-title":"The assessment of refill compliance using pharmacy records: methods, validity, and applications","volume":"50","author":"Steiner","year":"1997","journal-title":"J. Clin. Epidemiol."},{"key":"10.1016\/j.jad.2025.119443_bb0300","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/ncprheum0652","article-title":"Primer: administrative health databases in observational studies of drug effects--advantages and disadvantages","volume":"3","author":"Suissa","year":"2007","journal-title":"Nat. Clin. Pract. Rheumatol."},{"key":"10.1016\/j.jad.2025.119443_bb0305","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41398-022-02129-z","article-title":"A bitter pill to swallow? Impact of affective temperaments on treatment adherence: a systematic review and meta-analysis","volume":"12","author":"Szabo","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.jad.2025.119443_bb0310","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/cap.2017.0140","article-title":"Decreasing trend in the use and long-term use of benzodiazepines among young adults","volume":"28","author":"T\u00e4hk\u00e4p\u00e4\u00e4","year":"2018","journal-title":"J. Child Adolesc. Psychopharmacol."},{"key":"10.1016\/j.jad.2025.119443_bb0315","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2147\/PPA.S205359","article-title":"Using the medication adherence reasons scale (MAR-scale) to identify the reasons for non-adherence across multiple disease conditions","volume":"13","author":"Unni","year":"2019","journal-title":"PPA"},{"key":"10.1016\/j.jad.2025.119443_bb0320","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2125.2012.04167.x","article-title":"A new taxonomy for describing and defining adherence to medications","volume":"73","author":"Vrijens","year":"2012","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.jad.2025.119443_bb0325","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/pds.3457","article-title":"The Nordic prescription databases as a resource for pharmacoepidemiological research\u2014a literature review","volume":"22","author":"Wettermark","year":"2013","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.jad.2025.119443_bb0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0255192","article-title":"Pharmacotherapy, drug-drug interactions and potentially inappropriate medication in depressive disorders","volume":"16","author":"Wolff","year":"2021","journal-title":"PloS One"},{"key":"10.1016\/j.jad.2025.119443_bb0335","series-title":"Global Health Estimates (No. WHO\/MSD\/MER\/2017.2), World Health Organization","article-title":"Depression and other common mental disorders","author":"World Health Organisation","year":"2017"},{"key":"10.1016\/j.jad.2025.119443_bb0340","series-title":"Adherence to Long-Therm Therapies: Evidence for Action","year":"2003"},{"key":"10.1016\/j.jad.2025.119443_bb0345","first-page":"221","article-title":"Adherence to long-term therapies evidence for action","volume":"24","author":"World Health Organization","year":"2004","journal-title":"Ann. Saudi Med."},{"key":"10.1016\/j.jad.2025.119443_bb0350","series-title":"Suicide Worldwide in 2019: Global Health Estimates","author":"World Health Organization","year":"2021"},{"key":"10.1016\/j.jad.2025.119443_bb0355","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1002\/pds.4962","article-title":"Use of real-world evidence in regulatory decisions for rare diseases in the United States\u2014current status and future directions","volume":"29","author":"Wu","year":"2020","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.jad.2025.119443_bb0360","doi-asserted-by":"crossref","DOI":"10.3389\/frai.2023.1229609","article-title":"A risk identification model for detection of patients at risk of antidepressant discontinuation","volume":"6","author":"Zolnour","year":"2023","journal-title":"Front. Artif. Intell."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725008791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725008791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T09:44:33Z","timestamp":1762249473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032725008791"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":72,"alternative-id":["S0165032725008791"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2025.119443","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of therapeutic adherence to antidepressants and associated factors in patients with depressive disorder: A population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2025.119443","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"119443"}}